Andrew D. Yeoman
Newport, WLS, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
The ethics of unlicensed therapy use in primary biliary cholangitis: a counter view.
Journal: Nature reviews. Gastroenterology & hepatology
Published: February 19, 2026
Incidence rate and associated patient characteristics of liver disease in Wales 2004-2022: a retrospective population-scale observational study.
Journal: BMJ open
Published: February 10, 2025
Implementation of a care bundle improves PBC management.
Journal: JHEP reports : innovation in hepatology
Published: December 08, 2024
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?
Journal: Hepatology (Baltimore, Md.)
Published: February 09, 2024
Supportive and palliative care needs in advanced non-malignant liver disease: systematic review.
Journal: BMJ supportive & palliative care
Published: January 22, 2024
Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practice.
Journal: The lancet. Gastroenterology & hepatology
Published: November 02, 2023
Critical shortfalls in the management of PBC: Results of a UK-wide, population-based evaluation of care delivery.
Journal: JHEP reports : innovation in hepatology
Published: July 28, 2023
Pragmatic strategies to address health disparities along the continuum of care in chronic liver disease.
Journal: Hepatology communications
Published: May 01, 2023
Exploring changing attitudes to non-invasive liver fibrosis tests in secondary care pathways: comparison of two national surveys.
Journal: Frontline gastroenterology
Published: March 13, 2023
Predicting hepatic encephalopathy in patients with cirrhosis: A UK population-based study and validation of risk scores.
Journal: Hepatology communications
Published: November 17, 2022
Last Updated: 09/26/2026